GOLD 2017 Guidelines
The GOLD Science Committee was established in 2002 to review published research on COPD management and prevention, to evaluate the impact of this research on recommendations in the GOLD documents related to management and prevention, and to post yearly updates on the GOLD website. These publications are the worldwide consensus for best practice which are updated every year.
When deciding the appropriate pharmacotherapy, GOLD guidelines are very clear in the subjective monitoring of the patient, rather than severity of disease. The aim of pharmacotherapy is to reduce symptoms and reduce future risk.
Resources
 |
|---|
Global Strategy for the Diagnosis, Management and Prevention of COPD
The GOLD report has been used worldwide as a “strategy document” for healthcare professionals to use as a tool to implement effective management programmes based on local healthcare systems. The ABCD assessment tool has been used by many to structure their assessment of COPD symptom burden and create treatment plans.
